Jonathan Bijron
BIG-number: 19913486101
"Only by continuously evolving can pathology maintain its pivotal role in (oncological) care. Recent developments in the field offer new and exciting opportunities to meet the challenges of our time, and I am convinced that Pathology-DNA is the best partnership to respond to these challenges."
Jonathan Bijron studied medicine at the University Medical Center Utrecht (UMCU) and, after a period as a research fellow in Boston, began his pathology residency there in 2012. He also received his PhD in 2012 for his research on precursor lesions in serous adenocarcinoma of gynecological origin. After his residency, he started working as a pathologist at Martini Hospital Groningen in 2016 and, with the exception of a year at Antoni van Leeuwenhoek Hospital, worked there until 2025, the last four years of which he served as medical manager and board member of the northern regional collaborative association Pathology North. In September 2025, he joined Pathology-DNA, Nieuwegein location.
Fields of interest
- Gynecopathology
- Gastrointestinal pathology
- Urogenital Pathology
Publications
- Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis
- Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models
- Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers
- Pubmed